Investigation of the apoptotic pathway induced by benzimidazole-oxindole conjugates against human breast cancer cells MCF-7

被引:15
作者
Nayak, Vadithe Lakshma [1 ]
Nagaseshadri, Bobburi [1 ]
Vishnuvardhan, M. V. P. S. [1 ]
Kamal, Ahmed [1 ,2 ]
机构
[1] CSIR Indian Inst Chem Technol, Med Chem & Pharmacol, Hyderabad 500007, Andhra Pradesh, India
[2] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, Hyderabad 500037, Andhra Pradesh, India
关键词
Benzimidazole-oxindole conjugates; Breast cancer; Western blot analysis; Apoptosis; CYTOCHROME-C; BIOLOGICAL EVALUATION; MULTIDRUG-RESISTANCE; MEDIATED APOPTOSIS; MITOCHONDRIA; DEATH; FAS; BAX; ACTIVATION; CASPASES;
D O I
10.1016/j.bmcl.2016.05.045
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In our previous studies, benzimidazole-oxindole conjugates were synthesized and evaluated by National Cancer Institute (NCI) for their cytotoxic activity and the new molecules like 5c and 5p were considered as potential leads. These conjugates arrested the cell cycle at G2/M phase and inhibited tubulin polymerization. These observations prompted us to investigate the apoptotic mechanism induced by these lead molecules against human breast cancer cells (MCF-7). Studies like measurement of mitochondrial membrane potential (Delta psi(m)), generation of reactive oxygen species (ROS) and Annexin V-FITC assay revealed that these compounds induced mitochondrial mediated (intrinsic apoptotic pathway) apoptosis in human breast cancer cells. It was further confirmed by western blot analysis of pro apoptotic protein Bax, anti apoptotic protein Bcl-2, cytochrome c release, caspase-9 activity and cleavage of PARP. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3313 / 3317
页数:5
相关论文
共 32 条
  • [1] Synthesis and biological evaluation of new taxoids derived from 2-deacetoxytaxinine J
    Botta, Maurizio
    Armaroli, Silvia
    Castagnolo, Daniele
    Fontana, Gabriele
    Pera, Paula
    Bombardelli, Ezio
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (06) : 1579 - 1583
  • [2] Apoptosis in prostate carcinogenesis - A growth regulator and a therapeutic target
    Bruckheimer, EM
    Kyprianou, N
    [J]. CELL AND TISSUE RESEARCH, 2000, 301 (01) : 153 - 162
  • [3] Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay
    Cai, SX
    Nguyen, B
    Jia, SJ
    Herich, J
    Guastella, J
    Reddy, S
    Tseng, B
    Drewe, J
    Kasibhatla, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (12) : 2474 - 2481
  • [4] FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS
    CHINNAIYAN, AM
    OROURKE, K
    TEWARI, M
    DIXIT, VM
    [J]. CELL, 1995, 81 (04) : 505 - 512
  • [5] A NEW METHOD FOR THE CYTOFLUOROMETRIC ANALYSIS OF MITOCHONDRIAL-MEMBRANE POTENTIAL USING THE J-AGGREGATE FORMING LIPOPHILIC CATION 5,5',6,6'-TETRACHLORO-1,1',3,3'-TETRAETHYLBENZIMIDAZOLCARBOCYANINE IODIDE (JC-1)
    COSSARIZZA, A
    BACCARANICONTRI, M
    KALASHNIKOVA, G
    FRANCESCHI, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (01) : 40 - 45
  • [6] Pre-processed caspase-9 contained in mitochondria participates in apoptosis
    Costantini, P
    Bruey, JM
    Castedo, M
    Métivier, D
    Loeffler, M
    Susin, SA
    Ravagnan, L
    Zamzami, N
    Garrido, C
    Kroemer, G
    [J]. CELL DEATH AND DIFFERENTIATION, 2002, 9 (01) : 82 - 88
  • [7] Bax activation by Bim?
    Czabotar, P. E.
    Colman, P. M.
    Huang, D. C. S.
    [J]. CELL DEATH AND DIFFERENTIATION, 2009, 16 (09) : 1187 - 1191
  • [8] Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111
  • [9] Caspases: Keys in the ignition of cell death
    Denault, JB
    Salvesen, GS
    [J]. CHEMICAL REVIEWS, 2002, 102 (12) : 4489 - 4499
  • [10] Cancer Treatment and Survivorship Statistics, 2014
    DeSantis, Carol E.
    Lin, Chun Chieh
    Mariotto, Angela B.
    Siegel, Rebecca L.
    Stein, Kevin D.
    Kramer, Joan L.
    Alteri, Rick
    Robbins, Anthony S.
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (04) : 252 - 271